SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-15-055677
Filing Date
2015-09-21
Accepted
2015-09-21 08:05:26
Documents
13
Period of Report
2015-09-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v420588_8k.htm 8-K 18105
2 EXHIBIT 99.1 v420588_ex99-1.htm EX-99.1 7067
3 EXHIBIT 99.2 v420588_ex99-2.htm EX-99.2 10629
4 GRAPHIC image_001.jpg GRAPHIC 193689
5 GRAPHIC image_002.jpg GRAPHIC 388478
6 GRAPHIC image_003.jpg GRAPHIC 225022
7 GRAPHIC image_004.jpg GRAPHIC 167875
8 GRAPHIC image_005.jpg GRAPHIC 233465
9 GRAPHIC image_006.jpg GRAPHIC 343718
10 GRAPHIC image_007.jpg GRAPHIC 216950
11 GRAPHIC image_008.jpg GRAPHIC 339322
12 GRAPHIC image_009.jpg GRAPHIC 169025
13 GRAPHIC image_010.jpg GRAPHIC 80705
  Complete submission text file 0001144204-15-055677.txt   3284219
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 151116554
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1